CollPlant Biotechnologies (CLGN) Work In Process (2022 - 2025)
CollPlant Biotechnologies' (CLGN) quarterly Work In Process came in at $283000.0 in Q4 2025, down 1.05% YoY from $286000.0 in Q4 2024, and up 379.66% on a QoQ basis from $59000.0 in Q2 2025.
CollPlant Biotechnologies (CLGN) Work In Process (2022 - 2025) Analysis & Trends
CollPlant Biotechnologies (CLGN) has 4 years of Work In Process data on file, last reported at $283000.0 in Q4 2025.
- Quarterly Work In Process fell 1.05% year-over-year to $283000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $283000.0 (down 1.05% YoY) and the FY2025 annual result came in at $283000.0, down 1.05% from the prior year.
- Work In Process climbed to $283000.0 in Q4 2025, from $59000.0 in the prior quarter.
- In the past five years, Work In Process ranged from a high of $881000.0 in Q4 2022 to a low of $59000.0 in Q2 2025.
- A 4-year average of $368857.1 and a median of $283000.0 in 2025 frame the typical range for Work In Process.
- Annual changes were most pronounced in 2023 — Work In Process plunged 80.36% — and 2024, when it soared 65.32%.
- Tracing CLGN's Work In Process over 4 years: stood at $881000.0 in 2022, then sank by 80.36% to $173000.0 in 2023, then soared by 65.32% to $286000.0 in 2024, then retreated by 1.05% to $283000.0 in 2025.
- The last three Work In Process figures came in at $283000.0 (Q4 2025), $59000.0 (Q2 2025), and $286000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | CollPlant Biotechnologies | 4.13 Mn | 4.13 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 283,000.00 |
| Jun 30, 2025 | 59,000.00 |
| Dec 31, 2024 | 286,000.00 |
| Jun 30, 2024 | 218,000.00 |
| Dec 31, 2023 | 173,000.00 |
| Jun 30, 2023 | 682,000.00 |
| Dec 31, 2022 | 881,000.00 |